Table 11.6c

Immunosuppression Use for Induction by Steroid Use at Discharge, 2002 to 2006

Recipients with Heart Transplants

  No Steroids Used for Maintenance Steroids Used for Maintenance
N % N %
Functioning Graft with Immunosuppression Info at Discharge 633 100.0% 8,974 100.0%
Induction Drugs        
Atgam/NRATG/NRATS 72 11.4% 550 6.1%
OKT3 17 2.7% 339 3.8%
Thymoglobulin 159 25.1% 1,337 14.9%
Zenapax 65 10.3% 1,307 14.6%
Simulect 28 4.4% 1,037 11.6%
Campath 48 7.6% 33 0.4%
Rituximab     14 0.2%
No Induction Drug Reported 249 39.3% 4,651 51.8%


Source: OPTN/SRTR Data as of May 1, 2007.

Includes patients with a functioning graft at discharge.

Steroids used for induction are not counted.

Individual induction drug percentages will not necessarily add up to 100 percent, as patients may be prescribed more than one induction drug.